China equity: Chinese growth companies take Aim

Ying Fang: Three deals this year

While the IPO of China’s biggest commercial bank, ICBC, is setting records through its $20 billion-plus listing in Hong Kong and Shanghai, other Chinese companies are seeking a different route to raise cash. London’s Alternative Investment Market is hitting the radar screens of Chinese companies at the other end of the size spectrum. The latest firm poised to make an Aim listing is medical outfit China Medstar. Evolution Securities, a specialist China investment banking and securities firm, will arrange the deal, which will price some time this month and is expected to raise about £10 million ($18.7